1. Home
  2. OABI vs JMIA Comparison

OABI vs JMIA Comparison

Compare OABI & JMIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OmniAb Inc.

OABI

OmniAb Inc.

N/A

Current Price

$4.66

Market Cap

773.1M

Sector

Health Care

ML Signal

N/A

Logo Jumia Technologies AG each representing two

JMIA

Jumia Technologies AG each representing two

N/A

Current Price

$2.56

Market Cap

865.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
OABI
JMIA
Founded
2012
2012
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
773.1M
865.9M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
OABI
JMIA
Price
$4.66
$2.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$8.33
★ $8.58
AVG Volume (30 Days)
1.3M
★ 2.8M
Earning Date
10-30-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 6.56
N/A
EPS
N/A
★ N/A
Revenue
★ $18,666,000.00
N/A
Revenue This Year
$94.10
$33.12
Revenue Next Year
$30.33
$15.35
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.35
$2.27
52 Week High
$5.45
$14.72

Technical Indicators

Market Signals
Indicator
OABI
JMIA
Relative Strength Index (RSI) 42.52 17.71
Support Level $4.53 N/A
Resistance Level $5.43 $7.49
Average True Range (ATR) 0.32 0.42
MACD -0.05 -0.30
Stochastic Oscillator 4.76 6.95

Price Performance

Historical Comparison
OABI
JMIA

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

About JMIA Jumia Technologies AG each representing two

Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace that connects sellers with consumers. The logistics services of the company enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. The company generates revenue from first-party sales, third-party sales, marketing and advertising, and the provision of other services. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.

Share on Social Networks: